Nephros, Inc. (NEPH)
| Market Cap | 30.30M -49.8% |
| Revenue (ttm) | 21.58M +20.4% |
| Net Income | 1.91M +29.0% |
| EPS | 0.18 +28.0% |
| Shares Out | 10.86M |
| PE Ratio | 15.70 |
| Forward PE | 12.31 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 104,024 |
| Open | 3.080 |
| Previous Close | 3.090 |
| Day's Range | 2.720 - 3.080 |
| 52-Week Range | 2.663 - 6.420 |
| Beta | 1.75 |
| Analysts | Buy |
| Price Target | 6.25 (+124.01%) |
| Earnings Date | Nov 5, 2026 |
About NEPH
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that ... [Read more]
Financial Performance
In 2025, Nephros's revenue was $18.79 million, an increase of 32.67% compared to the previous year's $14.16 million. Earnings were $1.19 million, an increase of 1513.51%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for NEPH stock is "Buy." The 12-month stock price target is $6.25, which is an increase of 124.01% from the latest price.
News
Nephros price target lowered to $4.25 from $4.75 at Northland
Northland lowered the firm’s price target on Nephros (NEPH) to $4.25 from $4.75 and keeps a Market Perform rating on the shares.
Nephros Earnings Call Transcript: Q3 2026
Q3 revenue grew 18% YoY to $5.6M, and 9M revenue rose 20% to $16.9M with higher net income and adjusted EBITDA. Record active sites and expanding service and non-healthcare applications support growth, while costs and mix pressured margins.
Nephros Quarterly report: Q3 2026
Nephros has published its Q3 2026 quarterly earnings report on November 5, 2026.
Nephros Earnings release: Q3 2026
Nephros released its Q3 2026 earnings on November 5, 2026, summarizing the period's financial results.
Nephros Schedules Third Quarter 2026 Financial Results Conference Call
SOUTH ORANGE, N.J., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today annou...
Nephros Proxy statement: Proxy filing
Nephros filed a proxy statement on October 14, 2026, providing details for shareholder voting and corporate governance matters.
Nephros reports Q2 EPS 11c, consensus 0c
Reports Q2 revenue $6.02M, consensus $4.99M. “The second quarter of 2026 marks another significant milestone for Nephros (NEPH), as we delivered the highest quarterly revenue in the Company’s history,...
Nephros Earnings Call Transcript: Q2 2026
Record Q2 2026 revenue and net income were driven by broad-based growth in core products and services, aided by a one-time tariff refund. Service revenue nearly tripled, and new product launches are expected to drive future growth as market education and regulation increase.
Nephros Earnings release: Q2 2026
Nephros released its Q2 2026 earnings on August 6, 2026, summarizing the period's financial results.
Nephros Quarterly report: Q2 2026
Nephros has published its Q2 2026 quarterly earnings report on August 6, 2026.
Nephros initiated with a Market Perform at Northland
Northland initiated coverage of Nephros (NEPH) with a Market Perform rating and $4 price target The company’s five-nanometer ultrafilter is “the gold standard in preventing the spread of waterborne pa...
Nephros Transcript: Investor update
Revenue grew 7% to $5.2M in Q1, driven by programmatic and service growth, while gross margin declined to 57% due to tariffs and mix. Strategic focus is on expanding into new verticals, leveraging technology and education, and building recurring revenue through services. Margin recovery is expected as tariffs expire.
Nephros Slides: Corporate presentation
Nephros has posted slides in relation to its latest quarterly earnings report, which was published on July 15, 2026.
Nephros Announces Inclusion in the Russell Microcap® Index
SOUTH ORANGE, N.J., July 06, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today annou...
Nephros Earnings Call Transcript: Q1 2026
Record Q1 revenue of $5.2M was driven by 23% programmatic growth, offsetting lower emergency response sales. Gross margin fell to 57% due to tariffs, currency, and product mix, but margin improvement is expected as lower tariffs take effect.
Nephros Quarterly report: Q1 2026
Nephros has published its Q1 2026 quarterly earnings report on May 7, 2026.
Nephros Earnings release: Q1 2026
Nephros released its Q1 2026 earnings on May 7, 2026, summarizing the period's financial results.
Nephros Announces Financial Results for Quarter Ended March 31, 2026
SOUTH ORANGE, N.J., May 07, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announ...
Nephros Schedules First Quarter 2026 Financial Results Conference Call
SOUTH ORANGE, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today anno...
Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
SOUTH ORANGE, N.J., April 01, 2026 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today anno...
Nephros Slides: Corporate presentation
Nephros has posted slides in relation to its latest quarterly earnings report, which was published on March 27, 2026.
Nephros Earnings Call Transcript: Q4 2025
Revenue grew 33% to $18.8M in 2025 with net income of $1.2M, driven by programmatic sales and service expansion. Gross margin held at 62% for the year despite tariff pressures, and the company remains debt-free with $5.4M in cash.
Nephros Earnings release: Q4 2025
Nephros released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
Nephros Annual report: Q4 2025
Nephros has published its Q4 2025 annual report on March 12, 2026.
Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results
Full-Year Net Revenue Increased 33% Y-O-Y to $18.8 Million and Fourth-Quarter Net Revenue up 22% Y-O-Y to $4.7 Million Reports Second Consecutive Year of Positive Net Income SOUTH ORANGE, N.J., March ...